SAN FRANCISCO, CA—A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone ...
According to research by SNS Insider, the U.S. Viral Vector Manufacturing Market is projected to grow at a CAGR of 21.26%, driven by rapid expansion in gene therapy development, rising outsourcing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback